Use of romiplostim for antineoplastic therapy-induced thrombocytopenia in gynecologic and breast cancers

Objective: Romiplostim is used to treat chemotherapy-induced thrombocytopenia in a variety of tumor types; however, few studies have examined its use in breast and gynecologic cancers. We evaluated platelet response and durability of response to romiplostim in patients with gynecologic or breast can...

Full description

Bibliographic Details

Published in:	Gynecologic Oncology Reports
Main Authors:	Sara Moufarrij, Roisin E. O'Cearbhaill, Qin Zhou, Alexia Iasonos, Simon Mantha, Jeffrey Zwicker, Cy R. Wilkins
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Subjects:	Romiplostim Chemotherapy-induced thrombocytopenia Gynecologic cancer Breast cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S235257892400078X